Twist Bioscience (TWST) Asset Utilization Ratio (2018 - 2026)

Twist Bioscience (TWST) has reported Asset Utilization Ratio for 9 consecutive years, with 0.62 the latest figure, recorded in Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 7.91% year-over-year to 0.62; the TTM figure through Mar 2026 stood at 0.62 (up 7.91% YoY), while the FY2025 annual figure was 0.6, up 33.21% from the prior year.
• Asset Utilization Ratio climbed to 0.62 in Q1 2026 per TWST's latest filing, from 0.61 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.62 in Q1 2026 and bottomed at 0.18 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.4 across 5 years, with a median of 0.39 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio increased 1.8% — and 2024, when it soared 61.77%.
• Twist Bioscience's Asset Utilization Ratio stood at 0.23 in 2022, then surged by 50.76% to 0.35 in 2023, then surged by 55.32% to 0.54 in 2024, then climbed by 13.3% to 0.61 in 2025, then climbed by 1.84% to 0.62 in 2026.
• Business Quant data shows TWST's Asset Utilization Ratio at 0.62 in Q1 2026, 0.61 in Q4 2025, and 0.59 in Q3 2025.